Tandem Diabetes Care (TNDM) Assets Average (2014 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Assets Average came in at $1.2 billion in Q2 2026, up 28.35% on a YoY basis from $898.9 million in Q2 2025, and up 13.42% quarter-over-quarter from $1.0 billion in Q1 2026.
Analysis
Tandem Diabetes Care (TNDM) Assets Average (2014 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Assets Average for 13 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average rose 28.35% year-over-year to $1.2 billion; the trailing twelve-month figure through Jun 2026 stood at $1.2 billion (up 28.35% YoY), and the FY2025 full-year result was $924.4 million, down 3.73% from the prior year.
- Assets Average climbed to $1.2 billion in Q2 2026 per TNDM's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.2 billion in Q2 2026 and bottomed at $875.2 million in Q3 2025.
- Historically, Assets Average has averaged $971.5 million across 5 years, with a median of $949.0 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Assets Average surged 32.42% in 2022, then slipped 9.89% in 2023.
- Over 5 years, Assets Average stood at $1.1 billion in 2022, then fell by 9.89% to $946.3 million in 2023, then increased by 1.73% to $962.7 million in 2024, then decreased by 8.81% to $877.9 million in 2025, then surged by 31.43% to $1.2 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $1.2 billion, $1.0 billion, and $877.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Tandem Diabetes Care | 1.26 Bn | 804.14 Mn | 144.78 Mn | 1.15 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Bn |
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 877.88 Mn |
| Sep 30, 2025 | 875.19 Mn |
| Jun 30, 2025 | 898.94 Mn |
| Mar 31, 2025 | 944.90 Mn |
| Dec 31, 2024 | 962.69 Mn |
| Sep 30, 2024 | 947.62 Mn |
| Jun 30, 2024 | 939.27 Mn |
| Mar 31, 2024 | 946.85 Mn |
| Dec 31, 2023 | 946.28 Mn |
| Sep 30, 2023 | 943.29 Mn |
| Jun 30, 2023 | 950.41 Mn |
| Mar 31, 2023 | 1.00 Bn |
| Dec 31, 2022 | 1.05 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 1.03 Bn |
| Mar 31, 2022 | 960.21 Mn |
| Dec 31, 2021 | 877.71 Mn |
| Sep 30, 2021 | 822.76 Mn |